Literature DB >> 2298924

Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.

N B Oza1, J H Schwartz, H D Goud, N G Levinsky.   

Abstract

We have studied rat vascular smooth muscle (VSM) cells in culture for the presence of key elements of the glandular kallikrein-kinin system. Direct radioimmunoassay (RIA) using antiserum against rat urinary kallikrein detected a glandular kallikrein-like enzyme (GKLE) in VSM cells and in media. VSM homogenates and culture media had kininogenase activity, generating kinins from dog kininogen. About half of the GKLE was enzymatically inactive which could be activated with trypsin. Kininogenase activity was inhibited completely by aprotinin but only 20% by soybean trypsin inhibitor (SBTI). Trypsin liberated kinins from homogenates and media, demonstrating that VSM cells contain kininogen. Homogenates and media rapidly degrade bradykinin. GKLE, kininogen, and bradykininase activity were all present in VSM cells grown in defined media that contain no serum, thus eliminating any contamination or artefacts from fetal calf serum in standard culture media. Blood vessels of the rat have been reported to contain GKLE. Our observations indicate that GKLE is synthesized by VSM cells, not deposited from plasma. Furthermore, VSM cells synthesize kininogen and bradykininase(s), the other key elements of the glandular kallikrein-kinin system. Thus it is possible that the system functions as an autocoid mechanism that regulates local vascular tone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298924      PMCID: PMC296465          DOI: 10.1172/JCI114479

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Urinary kallikrein: a physiological regulator of epithelial Na+ absorption.

Authors:  S A Lewis; W P Alles
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

2.  Tissue-specific expression of kallikrein-related genes in the rat.

Authors:  P L Ashley; R J MacDonald
Journal:  Biochemistry       Date:  1985-08-13       Impact factor: 3.162

3.  Kallikrein activation of a high molecular weight atrial peptide.

Authors:  M G Currie; D M Geller; J Chao; H S Margolius; P Needleman
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

4.  Development of a rat urinary kallikrein-binding radioimmunoassay and identification of homologous enzyme in plasma.

Authors:  N B Oza
Journal:  J Clin Chem Clin Biochem       Date:  1981-10

5.  Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA.

Authors:  J Chao; C Woodley; L Chao; H S Margolius
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

6.  Components of the kallikrein-kinin system in rat urine.

Authors:  M S Weinberg; N B Oza; N G Levinsky
Journal:  Biochem Pharmacol       Date:  1984-06-01       Impact factor: 5.858

7.  Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein.

Authors:  H Nolly; A G Scicli; G Scicli; O A Carretero
Journal:  Circ Res       Date:  1985-06       Impact factor: 17.367

8.  The effect of cations on the activity of human urinary kallikrein.

Authors:  W Lieberthal; N B Oza; D B Bernard; N G Levinsky
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

9.  Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins.

Authors:  A D Cardin; K R Witt; J Chao; H S Margolius; V H Donaldson; R L Jackson
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

10.  Functional angiotensin II receptors in cultured vascular smooth muscle cells.

Authors:  S Gunther; R W Alexander; W J Atkinson; M A Gimbrone
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  23 in total

1.  Endothelial AT(2)-receptors: chicken or egg?

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

2.  Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function.

Authors:  A W Hahn; T J Resink; T Scott-Burden; J Powell; Y Dohi; F R Bühler
Journal:  Cell Regul       Date:  1990-08

Review 3.  Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

Authors:  H S Margolius
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 5.  Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.

Authors:  K Morgan
Journal:  Br Heart J       Date:  1994-09

6.  Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

Authors:  Michel Azizi; Pierre Boutouyrie; Alvine Bissery; Mohsen Agharazii; Francis Verbeke; Nora Stern; Alessandra Bura-Rivière; Stéphane Laurent; François Alhenc-Gelas; Xavier Jeunemaitre
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

7.  Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.

Authors:  Sigurdur T Sigurdsson; Olaf B Paulson; Arne Høj Nielsen; Svend Strandgaard
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  The myostimulating effect of tissue kallikrein on rat uterus.

Authors:  J Damas; V Bourdon; J C Pinto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

9.  Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells.

Authors:  Jerry G Webb; Yan Tan; Miran A Jaffa; Ayad A Jaffa
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

10.  Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response.

Authors:  B S Dixon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.